This bulletin provides information on offering individualised sick day guidance to patients when they are well, so that they are able to proactively manage medication known to impair renal function during illness or fever and reduce the risk of AKI.
View > >
This resource supports the implementation of the NHS England items which should not routinely be prescribed in primary care guidance.
View > >
This bulletin discusses the review of treatment with anticholinergic drugs and the different scales available to support review. Support materials are available to identify the risk in patients and support appropriate action to reduce anticholinergic burden.
View > >
This is an updated bulletin which includes new information on patient factors to consider before switching antiepileptic drugs, updated cost comparison charts and switch savings.
View > >
B172: Care homes Safeguarding and medicines
This bulletin discusses the issues around safeguarding in relation to medicines which could include: the deliberate withholding of medicine without a valid reason and incorrect use of medicines,
This bulletin discusses the use of co-proxamol and supports reviewing and discontinuing prescribing in patients still taking this unlicensed medicine.
View > >
The dependence forming medicines (DFMs) resources provide an overview of DFMs and signpost to PrescQIPP resources which support medicines optimisation projects in this area.
View > >
This bulletin aims to highlight the fire risk associated with emollient products and measures which need to be taken to reduce this risk.
View > >
B132: Fentanyl
This bulletin which is a DROP-List support bulletin will focus on fentanyl immediate-release formulations which has a NICE do not do as a first line treatment for breakthrough pain.
This bulletin offers advice on managing new patients with insomnia, recommends cost-effective prescribing choices, and encourages you to review chronic hypnotic users with a view to helping them withdraw from treatment.
View > >
Part 1 of this two part bulletin covers the assessment and management of chronic kidney disease (CKD) in line with NICE NG203 and drugs which are likely to cause kidney damage.
Part 2 covers the current advice prevention, detection and management of acute kidney injury (AKI) in line with NICE NG148.
View > >
These resources support the implementation of local campaigns for the World Health Organisation (WHO) global patient safety challenge, medication without harm.
View > >
This bulletin focuses on melatonin and provides information on ensuring that prescribing is appropriate, reviewing ongoing prescribing and deprescribing melatonin.
View > >
This bulletin and supporting materials review the place in therapy for modafinil in light of the MHRA restrictions on prescribing indications due to safety concerns.
View > >
These resources look at the safety implications of long term treatment with NSAIDs and support treatment initiation and review.
View > >
This bulletin and implementation resources focus on reducing PPI prescribing for safety reasons by reviewing the continued need and stepping down or deprescribing where appropriate in line with current guidance.
View > >
This bulletin offers guidance and background information on medicines safety. This includes the role of the Medicines Safety Officer (MSO) and the Medical Devices Safety Officer (MDSO).
View > >
